Maxim Group Downgrades Aytu BioPharma to Hold
Maxim Group analyst Naz Rahman downgrades Aytu BioPharma (NASDAQ:AYTU) from Buy to Hold.
Last updated: 2026-11-19 02:38:00. Prices reflect the latest closing data and will resume updating on the next trading day. Stock price data is sourced from Massive.
AYTU BioPharma, Inc. (AYTU) operates in the PHARMACEUTICAL PREPARATIONS sector and is listed on NASDAQ. The stock is currently priced at $2.66, with a market capitalization of $19.78M and a P/E ratio of --. Over the past 52 weeks, its price has ranged from $1.75 to $3.07. This page covers its latest market performance, valuation, price trends and company information.
$19.78M | |
$2.65 | |
$2.67 | |
$2.61 | |
$2.66 | |
371.41K | |
126.56K | |
-- | |
$3.07 | |
$1.75 | |
-- | |
2026-06-30 |
AYTU BioPharma, Inc. (AYTU) last closed at $2.66 as of 2026-11-19 00:31:00, down 0.19% ($0.01) from the previous close of $2.66.
During the latest regular trading session, AYTU traded between $2.61 and $2.67, with a volume of 371.41K shares. The closing price was near the upper end and near the upper end of its 52-week range.
AYTU is unchanged as of the last close.
Over the past seven days, AYTU BioPharma, Inc. (AYTU) moved from $1.79 to $2.66, representing a gain of 48.32% ($0.86).
The stock traded between $1.75 and $2.67 during the period. The latest price is near the upper end of the 7-day range, indicating strong upward.
The average daily volume was 865.12 thousand shares, up versus the previous seven-day period, indicating higher trading activity.
Position in Range: 68.8%
AYTU is currently trading at $2.66, placing it 68.8% of the way from its 52-week low of $1.75 to its 52-week high of $3.07. This percentage reflects the stock's relative position within its 52-week trading range, not its valuation or future performance.
Aytu BioPharma Inc is a pharmaceutical company focused on advancing innovative medicines for complex central nervous system diseases to improve the quality of life for patients. It has single operating segment. Its product portfolio includes EXXUA, ADHD Portfolio, Pediatric Portfolio, and Other. Majority of revenue comes from ADHD Portfolio. It has presence in United States.
| Industry | PHARMACEUTICAL PREPARATIONS |
| Employees | 76 |
| Exchange | NASDAQ |
| Company Website |
Latest news related to AYTU BioPharma, Inc. and AYTU stock.
Maxim Group analyst Naz Rahman downgrades Aytu BioPharma (NASDAQ:AYTU) from Buy to Hold.
Gainers SELLAS Life Sciences Gr (NASDAQ:SLS) shares rose 169.8% to $20.16 during Tuesday's regular session. The market value of their outstanding shares is at $1.5 billion. As per the press release, Q3 earnings
Gainers Aytu BioPharma (NASDAQ:AYTU) shares rose 45.0% to $2.64 during Tuesday's pre-market session. The market value of their outstanding shares is at $19.7 million. The company's, Q1 earnings came out
Aytu Biopharma surged 42.9% after strong revenue and a proposed Rosemont acquisition; Cloudastructure led gainers, while Bridger Aerospace and Stem fell.
Aytu BioPharma shares surged after hours as investors assessed results and acquisition terms.
Eligible investors can buy real shares of AYTU BioPharma, Inc. (AYTU) through MEXC RealStocks. Follow these three steps to open a RealStocks account, transfer USDT, and place a US stock order.
Stock prices and market data on this page, including price changes and market status, are provided by Massive and other third-party news and data platforms. Market data may be delayed and may differ from prices on other platforms or the prices at which trades are executed on MEXC. MEXC does not guarantee the accuracy, completeness, or timeliness of third-party data. MEXC offers trading products related to AYTU, including Stocks, Tokenized Stocks, and Stock Futures.
The stock price information displayed on this page is provided for reference purposes only and may be delayed or differ from real-time market data. Prices, charts, and related metrics do not constitute investment advice and should not be relied upon for trading or investment decisions. MEXC is not responsible for any losses incurred based on the stock price information provided on this page. Please refer to official market sources or consult licensed financial professionals before making any investment decisions.
Estimate the value between AYTU shares and USD.
AYTU Shares to USD
1.00 AYTU shares = 2.655 USD
Calculations are estimates based on the latest available price and are for reference only.